hydroxyproline has been researched along with calcitonin in 32 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (37.50) | 18.7374 |
1990's | 19 (59.38) | 18.2507 |
2000's | 1 (3.13) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Karachalios, T; Lyritis, GP; Magiasis, B; Tsakalakos, N; Tsekoura, M; Yiatzides, A | 1 |
Dunstan, CR; Evans, M; Evans, RA; Hills, E; Somers, NM | 1 |
Collette, J; Denis, D; Deroisy, R; Franchimont, P; Gennari, C; Lecart, MP; Mautalen, C; Reginster, JY; Vandalem, JL | 1 |
Dambacher, MA; Fischer, JA; Muff, R; Perrenoud, A; Simon, C | 1 |
Ghiringhelli, G; Gonzalez, D; Mautalen, C; Vega, E | 2 |
Albert, A; Denis, D; Deroisy, R; Fontaine, MA; Franchimont, P; Lambelin, P; Lecart, MP; Reginster, JY | 1 |
Antonelli, R; Cervellin, GF; Francini, G; Gennari, C; Gonnelli, S; Mazzuoli, GF; Minisola, S; Palummeri, E; Passeri, M; Valtorta, C | 1 |
Ghiringhelli, G; González, D; Mautalen, C | 1 |
Bevan, J; Fonseca, J; Gera, I; Gunness-Hey, M; Hock, JM; Poser, J; Raisz, LG | 1 |
Bertocchi, G; Gnudi, S; Mongiorgi, R; Moroni, A | 1 |
Cantatore, FP; Carrozzo, M; D'Amore, M; Magli, DM; Pipitone, V | 1 |
Berkarda, B; Derman, U; Serdengeçti, K; Serdengeçti, S | 1 |
Albert, A; Franchimont, P; Reginster, JY | 1 |
Kovitz, KL; Krane, IM; Krane, SM; Simon, LS; Wortman, PD | 1 |
Chapuy, MC; Delmas, PD; Meunier, PJ | 1 |
Balint-Perić, LA; Beslagić, Z; Petrović, J; Prelević, GM | 1 |
de Longueville, M; Deroisy, R; Franchimont, P; Jupsin, I; Lecart, MP; Reginster, JY; Sarlet, N; Zegels, B | 1 |
Bar-Shalom, R; Luboshitzky, R | 1 |
Albert, A; Biquet, I; Deroisy, R; Franchimont, P; Jupsin, I; Meurmans, L; Reginster, JY | 1 |
Dell'Acqua, S; Mango, D; Manna, P; Natili, G; Ricci, S | 1 |
Daugaard, H; Kollerup, G; Schifter, S; Skousgaard, SG; Sørensen, OH; Thamsborg, G | 1 |
Hazenberg, G; Kwakkel, G; Lips, P; Nauta, J; Netelenbos, JC; van der Vijgh, WJ; van der Wiel, HE | 1 |
di Giovanni, G; Giannattasio, R; Lettera, AM; Nunziata, CA; Nunziata, V | 1 |
Montemagno, U; Riccio, S; Romano, L; Ronsini, S; Tolino, A | 1 |
Agnusdei, D; Camporeale, A; Gennari, C | 1 |
Ionova, D; Kirjakov, Z; Zlatarska, S | 1 |
Cepollaro, C; Gennari, C; Gennari, L; Gonnelli, S; Montagnani, A; Montomoli, M; Palmieri, R | 1 |
Aubin, F; Cohen, C; Combe, B | 1 |
Bayraktar, M; Gedik, O; Gürlek, A | 1 |
Antoniou, G; Chryssikopoulos, A; Grigoriou, O; Konidaris, S; Papadias, C; Papoulias, I; Vitoratos, N | 1 |
Davey, RA; Morris, HA | 1 |
18 trial(s) available for hydroxyproline and calcitonin
Article | Year |
---|---|
Analgesic effect of salmon calcitonin in osteoporotic vertebral fractures: a double-blind placebo-controlled clinical study.
Topics: Aged; Analgesics; Calcitonin; Calcium; Double-Blind Method; Female; Humans; Hydroxyproline; Osteoporosis, Postmenopausal; Pain; Spinal Fractures | 1991 |
Treatment of Paget's disease of bone with a combination of intranasal salmon calcitonin and oral calcium and thiazide.
Topics: Administration, Intranasal; Administration, Oral; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Benzothiadiazines; Calcitonin; Calcium; Creatine; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Sodium Chloride Symporter Inhibitors | 1991 |
Acute effect of the intranasal administration of salmon calcitonin in osteoporotic women.
Topics: Administration, Intranasal; Aged; Calcitonin; Calcium; Creatinine; Female; Humans; Hydroxyproline; Middle Aged; Osteoporosis, Postmenopausal; Phosphates; Random Allocation | 1989 |
1-Year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin.
Topics: Administration, Intranasal; Bone and Bones; Calcitonin; Calcium; Clinical Trials as Topic; Creatinine; Drug Therapy, Combination; Female; Humans; Hydroxyproline; Minerals; Osteoporosis; Radionuclide Imaging; Random Allocation; Tablets; Time Factors | 1987 |
Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study.
Topics: Aged; Bone and Bones; Calcitonin; Calcium; Clinical Trials as Topic; Creatinine; Double-Blind Method; Female; Humans; Hydroxyproline; Menopause; Middle Aged; Minerals; Osteoporosis | 1986 |
Densitometric analysis in in vivo evaluation of synthetic salmon calcitonin activity.
Topics: Aged; Aging; Alkaline Phosphatase; Bone and Bones; Calcitonin; Calcium Carbonate; Densitometry; Female; Humans; Hydroxyproline; Middle Aged; Osteoporosis | 1988 |
Salmon calcitonin in the treatment of bone metastases.
Topics: Adult; Aged; Alkaline Phosphatase; Bone Neoplasms; Calcitonin; Calcium; Female; Follow-Up Studies; Humans; Hydroxyproline; Male; Middle Aged; Pain; Time Factors | 1986 |
The effect of intranasal salmon calcitonin on biochemical parameters of bone turnover in postmenopausal women.
Topics: Administration, Intranasal; Adult; Alkaline Phosphatase; Bone and Bones; Calcitonin; Calcium; Circadian Rhythm; Female; Humans; Hydroxyproline; Middle Aged; Osteocalcin; Parathyroid Hormone; Phosphorus; Postmenopause; Time Factors | 1994 |
A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss.
Topics: Administration, Intranasal; Alkaline Phosphatase; Animals; Bone Density; Bone Remodeling; Calcitonin; Calcium; Creatinine; Double-Blind Method; Female; Humans; Hydroxyproline; Lumbosacral Region; Middle Aged; Osteoporosis, Postmenopausal; Spine | 1995 |
A 5-year controlled randomized study of prevention of postmenopausal trabecular bone loss with nasal salmon calcitonin and calcium.
Topics: Absorptiometry, Photon; Alkaline Phosphatase; Bone Density; Calcitonin; Calcium; Calcium, Dietary; Creatinine; Female; Humans; Hydroxyproline; Lumbar Vertebrae; Osteoporosis, Postmenopausal | 1994 |
Preventive treatment of cortical bone loss with salmon nasal calcitonin in early postmenopausal women.
Topics: Absorptiometry, Photon; Administration, Intranasal; Administration, Oral; Alkaline Phosphatase; Biomarkers; Bone Resorption; Calcitonin; Calcium; Double-Blind Method; Female; Gonadal Steroid Hormones; Humans; Hydroxyproline; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Risk Factors; Sex Hormone-Binding Globulin | 1993 |
Acute effects of nasal salmon calcitonin on calcium and bone metabolism.
Topics: Administration, Intranasal; Adult; Alkaline Phosphatase; Amino Acids; Animals; Biomarkers; Bone and Bones; Bone Resorption; Calcitonin; Calcium; Humans; Hydroxyproline; Male; Osteocalcin; Osteogenesis; Peptide Fragments; Procollagen; Salmon | 1993 |
Intranasal calcitonin suppresses increased bone resorption during short-term immobilization: a double-blind study of the effects of intranasal calcitonin on biochemical parameters of bone turnover.
Topics: Administration, Intranasal; Adult; Bed Rest; Bone and Bones; Bone Resorption; Calcitonin; Calcium; Collagen; Collagen Type I; Creatinine; Double-Blind Method; Female; Humans; Hydroxyproline; Immobilization; Intervertebral Disc Displacement; Male; Middle Aged; Pain Measurement; Peptides | 1993 |
Effect of salmon calcitonin nasal spray on bone mass in patients with high turnover osteoporosis.
Topics: Administration, Intranasal; Adult; Aerosols; Bone and Bones; Bone Density; Calcitonin; Female; Humans; Hydroxyproline; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Time Factors | 1993 |
Treatment of post-menopausal osteoporosis with recombinant human growth hormone and salmon calcitonin: a placebo controlled study.
Topics: Amino Acids; Analgesics; Bone Density; Calcitonin; Calcium; Drug Therapy, Combination; Female; Femur; Human Growth Hormone; Humans; Hydroxyproline; Lumbar Vertebrae; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Placebos; Radius | 1997 |
Equivalence of nasal spray and subcutaneous formulations of salmon calcitonin.
Topics: Administration, Intranasal; Adult; Aerosols; Aged; Aged, 80 and over; Analgesics; Calcitonin; Calcium; Creatinine; Double-Blind Method; Female; France; Humans; Hydroxyproline; Injections, Subcutaneous; Longitudinal Studies; Male; Middle Aged; Pain; Spinal Fractures; Therapeutic Equivalency; Treatment Outcome | 1997 |
Comparison of calcitriol treatment with etidronate-calcitriol and calcitonin-calcitriol combinations in Turkish women with postmenopausal osteoporosis: a prospective study.
Topics: Absorptiometry, Photon; Administration, Intranasal; Aged; Analysis of Variance; Biomarkers; Bone Density; Calcitonin; Calcitriol; Drug Synergism; Drug Therapy, Combination; Etidronic Acid; Female; Humans; Hydroxyproline; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Prospective Studies; Treatment Outcome; Turkey | 1997 |
Effects of nasal administration of calcitonin in oophorectomized women: 2-year controlled double-blind study.
Topics: Administration, Intranasal; Adult; Analgesics; Bone Density; Calcitonin; Calcium; Cohort Studies; Creatinine; Double-Blind Method; Female; Humans; Hydroxyproline; Middle Aged; Osteocalcin; Ovariectomy; Postmenopause | 1997 |
14 other study(ies) available for hydroxyproline and calcitonin
Article | Year |
---|---|
Influence of specific anti-salmon calcitonin antibodies on biological effectiveness of nasal salmon calcitonin in Paget's disease of bone.
Topics: Administration, Intranasal; Adult; Aged; Alkaline Phosphatase; Animals; Antibodies; Antibody Specificity; Calcitonin; Creatine; Female; Humans; Hydroxyproline; Immunoglobulin G; Male; Middle Aged; Osteitis Deformans | 1990 |
Efficacy of intranasal human calcitonin in patients with Paget's disease refractory to salmon calcitonin.
Topics: Administration, Intranasal; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Antibodies; Calcitonin; Calcium; Drug Resistance; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans | 1990 |
Acute antiosteoclastic effect of salmon calcitonin in osteoporotic women.
Topics: Aged; Calcitonin; Calcium; Female; Humans; Hydroxyproline; Middle Aged; Osteitis Deformans; Osteoclasts; Osteoporosis; Phosphates | 1986 |
Human parathyroid hormone (1-34) and salmon calcitonin do not reverse impaired mineralization produced by high doses of 1,25 dihydroxyvitamin D3.
Topics: Animals; Bone and Bones; Calcitonin; Calcitriol; Calcium; Calcium-Binding Proteins; Hydroxyproline; Male; Osteocalcin; Osteogenesis; Osteomalacia; Parathyroid Hormone; Peptide Fragments; Rats; Rats, Inbred Strains; Teriparatide | 1986 |
Comparison of the acute effect of the intranasal and intramuscular administration of salmon calcitonin in Paget's disease.
Topics: Administration, Intranasal; Aged; Aged, 80 and over; Calcitonin; Drug Administration Schedule; Female; Humans; Hydroxyproline; Injections, Intramuscular; Male; Middle Aged; Osteitis Deformans | 1987 |
Evaluation of mineral metabolism and bone turnover in osteoporotic females treated with phosphorus and salmon calcitonin.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alkaline Phosphatase; Bone and Bones; Calcitonin; Calcitriol; Calcium; Calcium-Binding Proteins; Drug Therapy, Combination; Female; Humans; Hydroxyproline; Middle Aged; Minerals; Osteocalcin; Osteoporosis; Parathyroid Hormone; Phosphorus | 1987 |
Salmon-calcitonin nasal spray in Paget's disease of bone: preliminary results in five patients.
Topics: Administration, Intranasal; Aged; Alkaline Phosphatase; Calcitonin; Creatinine; Female; Follow-Up Studies; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Radiography | 1985 |
Serum levels of type I and III procollagen fragments in Paget's disease of bone.
Topics: Antibody Specificity; Calcitonin; Clodronic Acid; Humans; Hydroxyproline; Osteitis Deformans; Peptide Fragments; Procollagen; Radioimmunoassay; Time Factors | 1984 |
Paradoxical acute hypercalcemic effect of salmon calcitonin in patients having Paget's disease of bone after treatment with dichloromethylene diphosphonate.
Topics: Alkaline Phosphatase; Bone and Bones; Calcitonin; Calcium; Clodronic Acid; Diphosphonates; Humans; Hydroxyproline; Osteitis Deformans | 1984 |
[Calcitonin nasal spray for Paget's disease of the bone].
Topics: Administration, Intranasal; Adult; Aerosols; Aged; Alkaline Phosphatase; Analgesics; Calcitonin; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans | 1995 |
Vitamin D status in Paget's bone disease. Effects of calcitonin therapy.
Topics: 24,25-Dihydroxyvitamin D 3; Adult; Aged; Alkaline Phosphatase; Calcifediol; Calcitonin; Calcitriol; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Parathyroid Hormone; Time Factors; Vitamin D | 1993 |
Treatment of postmenopausal osteoporosis with salmon calcitonin nasal spray: evaluation by bone mineral content and biochemical patterns.
Topics: Absorptiometry, Photon; Administration, Inhalation; Aerosols; Bone and Bones; Calcitonin; Calcium; Female; Humans; Hydroxyproline; Middle Aged; Osteoporosis, Postmenopausal; Pain | 1993 |
Is calcitonin a helper of phosphate binders in the control of renal osteodystrophy?
Topics: Alkaline Phosphatase; Calcitonin; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Glycosaminoglycans; Humans; Hydroxyproline; Phosphates | 1995 |
The effects of salmon calcitonin-induced hypocalcemia on bone metabolism in ovariectomized rats.
Topics: Animals; Body Weight; Bone and Bones; Calcitonin; Calcium; Estrogens; Female; Homeostasis; Hydroxyproline; Hypocalcemia; Ovariectomy; Parathyroid Hormone; Rats; Rats, Sprague-Dawley; Time Factors | 2005 |